Research and Markets: Dyspnea - Pipeline Review, H2 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pdqll4/dyspnea) has announced the addition of Global Markets Direct's new report "Dyspnea - Pipeline Review, H2 2012" to their offering.

Global Markets Direct's, 'Dyspnea - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Dyspnea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dyspnea. Dyspnea - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Dyspnea.

- A review of the Dyspnea products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Dyspnea pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Key Topics Covered:

• Introduction
• Report Coverage
• Dyspnea Overview
• Therapeutics Development
• An Overview of Pipeline Products for Dyspnea
• Dyspnea Therapeutics under Investigation by Universities/Institutes 8
• Late Stage Products
• Comparative Analysis
• Mid Clinical Stage Products
• Comparative Analysis
• Dyspnea Therapeutics - Products under Investigation by Universities/Institutes
• Dyspnea - Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Drug Profiles
• dexamethasone acetate - Drug Profile
• sertraline hydrochloride - Drug Profile
• sertraline hydrochloride - Drug Profile
• Morphine + Coloxyl + Senna - Drug Profile
• Morphine + Clonazepam - Drug Profile
• Furosemide + Tolvaptan - Drug Profile
• Dyspnea Therapeutics - Dormant Products
• Appendix
• Methodology
• Coverage
• Secondary Research
• Primary Research
• Expert Panel Validation
• Contact Us
• Disclaimer

For more information visit http://www.researchandmarkets.com/research/pdqll4/dyspnea

Source: Global Markets Direct